EPITOGENX LIMITED

Company Documents

DateDescription
22/09/2522 September 2025 NewConfirmation statement made on 2025-09-15 with no updates

View Document

05/06/255 June 2025 Accounts for a dormant company made up to 2024-09-30

View Document

03/06/243 June 2024 Unaudited abridged accounts made up to 2023-09-30

View Document

20/03/2420 March 2024 Statement of capital following an allotment of shares on 2024-03-18

View Document

18/03/2418 March 2024 Change of details for Charles Chunhua as a person with significant control on 2024-03-18

View Document

30/09/2330 September 2023 Annual accounts for year ending 30 Sep 2023

View Accounts

19/09/2319 September 2023 Confirmation statement made on 2023-09-15 with updates

View Document

20/02/2320 February 2023 Resolutions

View Document

20/02/2320 February 2023 Memorandum and Articles of Association

View Document

20/02/2320 February 2023 Resolutions

View Document

20/02/2320 February 2023 Resolutions

View Document

20/02/2320 February 2023 Resolutions

View Document

20/02/2320 February 2023 Resolutions

View Document

20/02/2320 February 2023 Statement of capital following an allotment of shares on 2023-02-14

View Document

20/02/2320 February 2023 Change of share class name or designation

View Document

20/02/2320 February 2023 Resolutions

View Document

17/02/2317 February 2023 Appointment of Dr Ayham Alnabulsi as a director on 2023-02-14

View Document

17/02/2317 February 2023 Appointment of Abd Al Rahman Al Nabulsi as a director on 2023-02-14

View Document

17/02/2317 February 2023 Termination of appointment of John Aaron Lau Shishido as a director on 2023-02-14

View Document

26/10/2226 October 2022 Appointment of Guofeng Xu as a director on 2022-10-20

View Document

21/10/2221 October 2022 Termination of appointment of Robert Anthony Kasprzak as a director on 2022-10-20

View Document

16/09/2216 September 2022 Incorporation

View Document


More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company